To provide more evidence to support the antioncogenic activity of NBAT-1 in the OXA-resistance of CRC, a xenograft mouse model was established by subcutaneously injecting either the HCT116/OXA or the SW480/OXA cells transfected with the NBAT-1 expressing vector. The gene discussed is NBAT1; the disease is colorectal carcinoma.